Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham CorpfiledCriticalSmithkline Beecham Corp
Priority to CO97016200ApriorityCriticalpatent/CO4520304A1/en
Publication of CO4520304A1publicationCriticalpatent/CO4520304A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
UN COMPUESTO QUE ES DIHIDRATO MONOMETANOSULFONATO DE ACIDO(E) -A- (2-N-BUTIL-1-94 CARBOXIFENIL)METIL )1H-IMIDAZO0-5-IL0 METILEN-2-TIOFENOPRPIONICO EN UNA SOLUCION ACUOSA QUE CONTIENEN ACIDO. UN PROCEDIMIENTO PARA LA PREPARACION DE UNA FORMA SOLIDA DE DOSIFICACION QUE CONTIENE EL COMPUESTO SEGUN LA REIVINDICACION 1, QUE COMPRENDE: I) PRODUCIR GRANULOS QUE CONTIENEN HIDRATO DE MONOMETANOSULFONATO DE ACIDO (E)-A (2-N-BUTIL-1- ((4-CARBOXI-FENIL)METIL)METIL)-1H-IMIDAZOL-5-IL) METINEL-2-TIOFENOPROPIONICO; Y II) MEZCLAR DICHOS GRANULOS CON OTROS EXCIPIENTES FARMACEUTICAMENTE ACEPTABLES PARA RELLENAR CON ELLOS UNA CAPSULA O PRODUCIR UN COMPRIMIDO.A COMPOUND WHICH IS ACID MONOMETHANOSULPHONATE ACID (E) -A- (2-N-BUTIL-1-94 CARBOXIFENIL) METHYL) 1H-IMIDAZO0-5-IL0 METHYLENE-2-THIOPHENOPRPIONIC IN AN AQUEOUS SOLUTION CONTAINING ACID. A PROCEDURE FOR THE PREPARATION OF A SOLID DOSAGE FORM CONTAINING THE COMPOUND ACCORDING TO CLAIM 1, WHICH INCLUDES: I) PRODUCING MONOMETHANULESULPHONATE ACID (E) -A (2-N-BUTYL-1- (( 4-CARBOXY-PHENYL) METHYL) METHYL) -1H-IMIDAZOL-5-IL) METINEL-2-THIOPHENOPROPIONIC; AND II) MIXING SUCH GRANULES WITH OTHER PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS TO FILL A CAPSULE WITH THEM OR PRODUCE A TABLET.
CO97016200A1997-04-011997-04-01
EPROSARTAN DIHYDRATE AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATION
CO4520304A1
(en)
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A 100 MG / ML HYDROSOLUBILITY, AND PROCEDURES FOR PREPARATION
SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES
TILUDRONATE COMPOUND, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS TO PRODUCE SUCH COMPOUND AND PROCEDURE TO PRODUCE PHARMACEUTICAL COMPOSITIONS.